Date: 2016-11-10
Type of information: Nomination
Compound: member of the board of directors
Company: Wave LIfe Sciences (USA - MA)
Therapeutic area: Rare diseases - Genetic diseases
Type agreement: nomination
Action mechanism:
Disease:
Details:
- • On November 10, 2016, WaveLife Sciences announced the appointment of Christian Henry, Executive Vice President & Chief Commercial Officer of Illumina, to its Board of Directors and as the Chair of its Audit Committee.
- Mr. Henry has more than 20 years of leadership experience, including over ten years in executive-level positions at Illumina, where he has been a key member of the team that has driven the company’s strategy, which has led to significant revenue growth for the organization. During his tenure at Illumina, Mr. Henry has served in multiple roles, including Chief Financial Officer, General Manager of Life Sciences, General Manager of Genomic Solutions and most recently Chief Commercial Officer. Mr. Henry oversaw the buildout of Illumina’s current research facility in the United Kingdom and the expansion of the company’s manufacturing facility in Singapore to over 150,000 square feet. He played leading roles in Illumina’s acquisitions of several life sciences companies, and led Illumina’s expansion into new life sciences markets. Prior to joining Illumina, Mr. Henry served as the Chief Financial Officer of Tickets.com, and prior to that, served as Vice President, Finance and Corporate Controller of Affymetrix. Prior to that, he served in various positions at Nektar Therapeutics, Sugen, and Ernst & Young. Mr. Henry earned his B.A. in biochemistry and cell biology from the University of California, San Diego, and his M.B.A., from the University of California, Irvine.
Financial terms:
Latest news:
Is general: Yes
